BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35338007)

  • 1. Single-Cell Analysis of Refractory Celiac Disease Demonstrates Inter- and Intra-Patient Aberrant Cell Heterogeneity.
    Dieckman T; Schreurs M; Mahfouz A; Kooy-Winkelaar Y; Neefjes-Borst A; Bouma G; Koning F
    Cell Mol Gastroenterol Hepatol; 2022; 14(1):173-192. PubMed ID: 35338007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II.
    Schmitz F; Tjon JM; Lai Y; Thompson A; Kooy-Winkelaar Y; Lemmers RJ; Verspaget HW; Mearin ML; Staal FJ; Schreurs MW; Cupedo T; Langerak AW; Mulder CJ; van Bergen J; Koning F
    Gut; 2013 Apr; 62(4):509-19. PubMed ID: 22760007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes.
    Kooy-Winkelaar YM; Bouwer D; Janssen GM; Thompson A; Brugman MH; Schmitz F; de Ru AH; van Gils T; Bouma G; van Rood JJ; van Veelen PA; Mearin ML; Mulder CJ; Koning F; van Bergen J
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E980-E989. PubMed ID: 28049849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease.
    Hrdlickova B; Mulder CJ; Malamut G; Meresse B; Platteel M; Kamatani Y; Ricaño-Ponce I; van Wanrooij RLJ; Zorro MM; Jan Bonder M; Gutierrez-Achury J; Cellier C; Zhernakova A; Nijeboer P; Galan P; Withoff S; Lathrop M; Bouma G; Xavier RJ; Jabri B; Bensussan NC; Wijmenga C; Kumar V
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):828-837. PubMed ID: 29787419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy in RCDII: Rationale for Combination Strategies?
    Nijeboer P; Malamut G; Bouma G; Cerf-Bensussan N; Koning F; van Bergen J; Cellier C; Mulder CJJ
    Dig Dis; 2015; 33(2):227-230. PubMed ID: 25925927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The composition and differentiation potential of the duodenal intraepithelial innate lymphocyte compartment is altered in coeliac disease.
    Schmitz F; Kooy-Winkelaar Y; Wiekmeijer AS; Brugman MH; Mearin ML; Mulder C; Chuva de Sousa Lopes S; Mummery CL; Staal FJ; van Bergen J; Koning F
    Gut; 2016 Aug; 65(8):1269-78. PubMed ID: 25966995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease.
    Hussein S; Gindin T; Lagana SM; Arguelles-Grande C; Krishnareddy S; Alobeid B; Lewis SK; Mansukhani MM; Green PHR; Bhagat G
    J Clin Pathol; 2018 Sep; 71(9):825-831. PubMed ID: 29703761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin and immunophenotype of aberrant IEL in RCDII patients.
    Tack GJ; van Wanrooij RL; Langerak AW; Tjon JM; von Blomberg BM; Heideman DA; van Bergen J; Koning F; Bouma G; Mulder CJ; Schreurs MW
    Mol Immunol; 2012 Apr; 50(4):262-70. PubMed ID: 22364936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients.
    Schmitz F; Tjon JM; van Bergen J; Koning F
    Mol Immunol; 2014 Mar; 58(1):10-6. PubMed ID: 24252355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Intracellular Intensity of CD3 on Aberrant Intraepithelial Lymphocytes Is a Prognostic Factor of the Progression to Overt Lymphoma in Refractory Celiac Disease Type II (Pre-Enteropathy-Associated T Cell Lymphoma).
    García-Hoz C; Crespo L; Lopez N; De Andrés A; Ríos León R; Santón A; Garriga M; Butz E; León F; Roy Ariño G
    Dig Dis; 2020; 38(6):490-499. PubMed ID: 32015237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory celiac disease and EATL patients show severe malnutrition and malabsorption at diagnosis.
    Wierdsma NJ; Nijeboer P; de van der Schueren MA; Berkenpas M; van Bodegraven AA; Mulder CJ
    Clin Nutr; 2016 Jun; 35(3):685-91. PubMed ID: 25979847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.
    Cheminant M; Bruneau J; Malamut G; Sibon D; Guegan N; van Gils T; Cording S; Trinquand A; Verkarre V; Lhermitte L; Brousse N; Jannot AS; Khater S; Frenzel L; Delarue R; Suarez F; Marçais A; Mulder CJ; Macintyre E; Asnafi V; Pouyet L; Bonnafous C; Lhospice F; Molina TJ; Meresse B; Cellier C; Cerf-Bensussan N; Hermine O;
    Gut; 2019 Aug; 68(8):1396-1405. PubMed ID: 30448772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenetic landscape of lymphomagenesis in coeliac disease.
    Cording S; Lhermitte L; Malamut G; Berrabah S; Trinquand A; Guegan N; Villarese P; Kaltenbach S; Meresse B; Khater S; Dussiot M; Bras M; Cheminant M; Tesson B; Bole-Feysot C; Bruneau J; Molina TJ; Sibon D; Macintyre E; Hermine O; Cellier C; Asnafi V; Cerf-Bensussan N;
    Gut; 2022 Mar; 71(3):497-508. PubMed ID: 33579790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
    Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
    Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory Celiac Disease.
    Malamut G; Cellier C
    Gastroenterol Clin North Am; 2019 Mar; 48(1):137-144. PubMed ID: 30711206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.
    Cellier C; Delabesse E; Helmer C; Patey N; Matuchansky C; Jabri B; Macintyre E; Cerf-Bensussan N; Brousse N
    Lancet; 2000 Jul; 356(9225):203-8. PubMed ID: 10963198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic yield of capsule endoscopy in refractory celiac disease.
    Barret M; Malamut G; Rahmi G; Samaha E; Edery J; Verkarre V; Macintyre E; Lenain E; Chatellier G; Cerf-Bensussan N; Cellier C
    Am J Gastroenterol; 2012 Oct; 107(10):1546-53. PubMed ID: 22964554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
    Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
    Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential IL-13 production by small intestinal leukocytes in active coeliac disease versus refractory coeliac disease.
    Gross S; van Wanrooij RL; Nijeboer P; Gelderman KA; Cillessen SA; Meijer GA; Mulder CJ; Bouma G; von Blomberg BM; Bontkes HJ
    Mediators Inflamm; 2013; 2013():939047. PubMed ID: 23690672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease.
    Verbeek WH; von Blomberg BM; Scholten PE; Kuik DJ; Mulder CJ; Schreurs MW
    Am J Gastroenterol; 2008 Dec; 103(12):3152-8. PubMed ID: 19086962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.